← Product Code [LEH](/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/LEH) · K963267

# VANCOMYCIN FLEX REAGENT CARTRIDGE (K963267)

_Dade Intl., Inc. · LEH · Sep 13, 1996 · Clinical Toxicology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/LEH/K963267

## Device Facts

- **Applicant:** Dade Intl., Inc.
- **Product Code:** [LEH](/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/LEH.md)
- **Decision Date:** Sep 13, 1996
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.3950
- **Device Class:** Class 2
- **Review Panel:** Clinical Toxicology

## Indications for Use

The VANC FLEX™ reagent cartridge used on the Dimension® clinical chemistry system is an in vitro diagnostic test intended to measure vancomycin, an antibiotic drug, in plasma and serum. Measurements obtained by this device are used in the diagnosis and treatment of vancomycin overdose and in monitoring the level of vancomycin to ensure appropriate therapy.

## Device Story

VANC FLEX™ reagent cartridge; used on Dimension® clinical chemistry system. Input: human plasma or serum samples. Principle: Particle Enhanced Turbidimetric Inhibition Immunoassay (PETINIA) using latex particle-vancomycin conjugate and vancomycin-specific monoclonal antibody. Output: quantitative vancomycin concentration (µg/mL). Used in clinical laboratory settings by trained personnel. Results assist clinicians in therapeutic drug monitoring and overdose management.

## Clinical Evidence

Bench testing comparing VANC FLEX™ on Dimension® system vs. aca® VANC test pack. Sample size: 231. Results: slope 0.95, intercept -0.33, correlation coefficient 0.987. Range: 0.1 - 49.8 µg/mL.

## Technological Characteristics

Particle Enhanced Turbidimetric Inhibition Immunoassay (PETINIA). Reagents: latex particle-vancomycin conjugate, vancomycin-specific monoclonal antibody. Form factor: prepackaged reagent cartridge for automated clinical chemistry analyzer.

## Regulatory Identification

A vancomycin test system is a device intended to measure vancomycin, an antibiotic drug, in serum. Measurements obtained by this device are used in the diagnosis and treatment of vancomycin overdose and in monitoring the level of vancomycin to ensure appropriate therapy.

## Predicate Devices

- aca® analytical test pack ([K963267](/device/K963267.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

DADE
K963267
SEP 13 1996
DADE INTERNATIONAL
Chemistry Systems
P.O. Box 6101
Newark, DE 19714

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92

## Vancomycin FLEX™ Reagent Cartridge

## Summary of Safety and Effectiveness

The VANC FLEX™ reagent cartridge used on the Dimension® clinical chemistry system is an *in vitro* diagnostic test intended to measure vancomycin, an antibiotic drug, in plasma and serum. Measurements obtained by this device are used in the diagnosis and treatment of vancomycin overdose and in monitoring the level of vancomycin to ensure appropriate therapy.

The VANC method is based on a Particle Enhanced Turbidimetric Inhibition Immunoassay (PETINIA) technique which uses a latex particle-vancomycin conjugate and vancomycin-specific monoclonal antibody.

The VANC FLEX™ reagent cartridge is substantially equivalent to the aca® analytical test pack, which was cleared by the FDA through the 510(k) process. Both tests used prepackaged reagents for the determination of vancomycin in human serum and plasma.

Two hundred thirty-one samples were tested with the VANC FLEX™ reagent cartridge on the Dimension® system and the aca® VANC test pack on the aca® discrete clinical analyzer, with the following results:

- slope = 0.95
- intercept = -0.33
- correlation coefficient = 0.987
- range of samples = 0.1 - 49.8 µg/mL

Carolyn K. George
Regulatory Affairs and
Compliance Manager

September 4, 1996
Date

Printed on recycled paper with 25% post-consumer fiber

---

**Source:** [https://fda.innolitics.com/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/LEH/K963267](https://fda.innolitics.com/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/LEH/K963267)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com